79367537

Information

• Trademark
• 79367537

• Source

• Serial Number

  79367537

• Registration Number

  7636536

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  March 21, 2023
  a year ago

• Registration Date

  January 07, 2025
  2 days ago

• Transaction Date

  January 07, 2025
  2 days ago

• Status Date

  January 07, 2025
  2 days ago

• Published for Opposition Date

  September 17, 2024
  3 months ago

• Location Date

  January 06, 2025
  3 days ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  FENNESSY, EDWARD

• Attorney Docket Number

  T61767705int

  Attorney Name

  Jacqueline Zion

• Owners

  • MILEUTIS LTD.

Case File Statements

• DM0000: The mark consists of a series of six shaded irregular oval-like shapes, the first appearing in the upper left corner of the mark and consisting of a irregular oval-like shape, to the lower right of which appears two larger irregular oval-like shapes in diagonal-right format, to the lower right of which appears two smaller irregular oval-like shapes in diagonal-right format, and the last appearing on the bottom right corner consisting of an even smaller irregular oval-like shape.
• GS0051: Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness

Case File Event Statements

• 4/13/2023 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/17/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/21/2023 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/16/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/16/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/17/2023 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/21/2023 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/21/2023 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 1/8/2024 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/19/2024 - 6 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/19/2024 - 6 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/19/2024 - 6 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/14/2024 - 4 months ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/28/2024 - 4 months ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/11/2024 - 4 months ago

  15 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 9/11/2024 - 4 months ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 9/17/2024 - 3 months ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/17/2024 - 3 months ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/30/2024 - 3 months ago

  19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 1/7/2025 - 2 days ago

  20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/7/2025 - 2 days ago

  21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC